期刊文献+

重症肌无力合并胸腺瘤的手术治疗和临床病理分析

The Clinicopathologic Features and Surgical Treatment of Myasthenia Gravis with Thymoma
下载PDF
导出
摘要 目的探讨重症肌无力(myasthenia gravis,MG)合并胸腺瘤患者的临床病理特点及合理的外科治疗方案。方法回顾性分析47例MG合并胸腺瘤患者的临床资料。其胸腺瘤Masaoka病理分型Ⅰ期22例,Ⅱ期12例,Ⅲ期13例;MG改良Osserman法分型Ⅰ型20例,Ⅱa型14例,Ⅱb型7例,Ⅲ型6型。采用胸骨正中切口23例,前胸切口19例,后外侧切口5例。以累积生存率、MG转归为指标进行统计分析。结果本组平均随诊76.5(10~178)月。①11例(显性MG10例,隐性MG1例)术后围手术期出现肌无力危象(23.4%)。全组随诊共6例死于MG(12.8%),7例死于胸腺瘤(14.9%)。②显性MG32例,术后随诊5年总完全缓解率达34.4%,总改善率为62.5%。隐性MG15例,发作时间平均为术后37.7(0~137)d,出现MG后的5年自然缓解率为25.0%。③影响MG转归的因素为术后围手术期是否出现危象,出现者MG转归较差(P<0.05)。④经COX模型预后多因素分析,随诊中MG病情反复且有加重(优势比OR=2.16),胸腺瘤病理分期(OR=2.03)和手术方式(OR=1.63)为影响预后的主要因素。结论扩大胸腺切除术、术后肿瘤综合治疗、MG的围手术期综合处理及其长期治疗是提高疗效的有效手段。 Objective To investigate the clinicopathologic characteristics and surgical treatment of myasthenia gravis (MG) with thymoma. Methods 47 cases of MG with thymoma were retrospectively reviewed. All cases divided into stage Ⅰ in 22, stage Ⅱ, in 12, stage Ⅲ in 13 according to Masaokag classification of thymoma,and grade Ⅰ in 20, grade Ⅱ a in 14, grade Ⅱb in 7 ,grade Ⅲ in 6 according to modified Osserman's classification of MG. The operations performed via a median longitudinal sternotomy in 23 cases, anterior thoracic incision in 19 cases and posterolateral incision in 5 cases. Statistic analysis performed in terms of accumulated survival rate and MG turnover. Result All cases were followed up from 10 to 178 (average 76.5) months. ①Myasthenic crisis occurred in 11 cases including 10 cases of visible MG and 1 case of invisible MG. 6 cases ( 12.8% ) died of MG and 7 cases(14.9) dief of thymoma in follow-up duration. ②The complete remission rate and general remission rate were 34.4% and 62.5% in 32 cases of visible MG according to 5 years follow-up. The average onset time was postoperative 37.7 (0 ~ 137) days and the 5-year spontenous remission rate was 25% in 15 cases of invisible MG. ③The occurrence of myasthenic crisis was significantly correlated with a poor prognosis (P 〈0.05). ④ Recurrence and deterioration of MG (OR =2.16), pathological staging of thymoma ( OR =2.03) and type of resection (OR=1.63 )were the independent prognostic variables according to COX multivariate regression model. Conclusion The extended thymectomy,comprehensive perioperative treatment, postoperative adjuvant therapy, and long-term follow up are the effective approaches to improve the prognosis.
出处 《中国现代手术学杂志》 2005年第4期251-254,共4页 Chinese Journal of Modern Operative Surgery
关键词 重症肌无力 胸腺肿瘤 预后 myasthenia gravis thymus neoplasms prognosis
  • 相关文献

参考文献13

  • 1蒋耀光,王如文,范士志,陈建民,雷军.重症肌无力合并胸腺瘤的外科治疗(附31例报告)[J].中华胸心血管外科杂志,1998,14(5):257-259. 被引量:46
  • 2李鉴,汪良骏,张汝刚,张大为,黄进丰.胸腺瘤的临床病理特征和预后[J].中华肿瘤杂志,1999,21(4):272-274. 被引量:20
  • 3Darid CS, Frank CS. Gibbon's surgery of chest[M]. 4th ed. Washington:W.B. Saunders company,1983. 849-869. 被引量:1
  • 4Rzyman W, Skokowski J, Marjanski T, et al. Thymectomy in myasthenia gravis[J]. Pol Merkuriusz Lek, 2005,18(103):41-44. 被引量:1
  • 5Glinjongol C,Paiboonpol S.Outcome after transsternal radical thy-mectomy for myasthenia gravis: 14-year review at Ratchaburi Hospital[J]. J Med Assoc Thai, 2004,87(11):1304-1310. 被引量:1
  • 6Petkov R, Kutev N, Mladenovski V,et al. Thymectomy for myastenia gravis:25-year experience[J]. Khirurgiia (Sofiia),2004,60(3):27-29. 被引量:1
  • 7Huang CS, Hsu HS, Huang BS, et al. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis[J]. Acta Neurol Scand,2005,112(2):108-114. 被引量:1
  • 8Masaoka A, Yamakawa Y, Niwa H, et al. Extended thymectomy for myasthenia gravis patients: a 20-year review[J]. Ann Thorac Surg, 1996, 62(3):853-859. 被引量:1
  • 9Watanabe A, Watanabe T, Obama T, et al. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis[J]. J Thorac Cardiovasc Surg,2004,127(3):868-876. 被引量:1
  • 10Drachman DB. Myasthenia gravis (first of two parts)[J]. N Engl J Med, 1978, 298(3):136-142. 被引量:1

二级参考文献5

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部